Literature DB >> 3689460

Subclinical lung inflammation in primary Sjögren's syndrome. Relationship between bronchoalveolar lavage cellular analysis findings and characteristics of the disease.

P Y Hatron1, B Wallaert, D Gosset, A B Tonnel, B Gosselin, C Voisin, B Devulder.   

Abstract

To directly evaluate whether a subclinical alveolar inflammation is associated with primary Sjögren's syndrome (SS), we evaluated the distribution of cells obtained by bronchoalveolar lavage (BAL) from the lower respiratory tract in 29 patients who had primary SS, but who were free of clinical pulmonary symptoms and had normal findings on chest roentgenograms. There was no difference in total cell counts of specimens from patients versus those of controls. An abnormal differential cell count was noted in 16 patients (55%). Two patterns of alveolitis were observed: a pure lymphocyte alveolitis (greater than 18% lymphocytes, present in 11 patients) and a neutrophil alveolitis (greater than 4% neutrophils, present in 5 patients). There was associated lymphocytosis in 4 of the patients with neutrophil alveolitis. All patients had normal results on pulmonary function tests. Patients with abnormal BAL findings showed clinical and biologic indexes of more severe disease than did those with normal BAL results, as demonstrated by greater extraglandular extension of the disease, higher mean values of serum gamma globulins and serum beta2-microglobulin, and higher prevalence of rheumatoid factor and of antinuclear antibody. Thus, our data demonstrate that BAL permitted the detection of subclinical inflammatory alveolitis in 55% of our patients with primary SS. A long-term followup is required to determine whether these patients will develop obvious pulmonary involvement.

Entities:  

Mesh:

Year:  1987        PMID: 3689460     DOI: 10.1002/art.1780301104

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  13 in total

Review 1.  Imaging of the pulmonary manifestations of systemic disease.

Authors:  A G Rockall; D Rickards; P J Shaw
Journal:  Postgrad Med J       Date:  2001-10       Impact factor: 2.401

2.  Lymphocytic alveolitis: A surprising index of poor prognosis in patients with primary Sjogren's syndrome.

Authors:  Y A Dalavanga; P V Voulgari; A N Georgiadis; C Leontaridi; S Katsenos; M Vassiliou; A A Drosos; S H Constantopoulos
Journal:  Rheumatol Int       Date:  2005-12-13       Impact factor: 2.631

Review 3.  Subclinical alveolitis in immunologic systemic disorders.

Authors:  B Wallaert
Journal:  Lung       Date:  1990       Impact factor: 2.584

4.  Phenotypic and functional activation of alveolar macrophages, T lymphocytes and NK cells in patients with systemic sclerosis and primary Sjögren's syndrome.

Authors:  B Gudbjörnsson; R Hällgren; O Nettelbladt; R Gustafsson; A Mattsson; E af Geijerstam; T H Tötterman
Journal:  Ann Rheum Dis       Date:  1994-09       Impact factor: 19.103

5.  Bronchoalveolar lavage in rheumatoid arthritis and secondary Sjögren's syndrome.

Authors:  W Popp; L Ritschka; O Scherak; O Braun; G Kolarz; H Rauscher; H Zwick
Journal:  Lung       Date:  1990       Impact factor: 2.584

6.  Lung function in primary Sjögren's syndrome: a cross sectional and longitudinal study.

Authors:  C Kelly; P Gardiner; B Pal; I Griffiths
Journal:  Thorax       Date:  1991-03       Impact factor: 9.139

Review 7.  Interstitial lung disease in systemic sclerosis.

Authors:  Predrag Ostojic; Marco Matucci Cerinic; Richard Silver; Kristin Highland; Nemanja Damjanov
Journal:  Lung       Date:  2007 Jul-Aug       Impact factor: 2.584

8.  A follow-up study of pulmonary function in patients with primary Sjögren's syndrome.

Authors:  M Linstow; N J Kriegbaum; V Backer; C Ulrik; P Oxholm
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

9.  Lymphocytic interstitial pneumonia as a manifestation of SLE and secondary Sjogren's syndrome.

Authors:  Daniel Garcia; Lary Young
Journal:  BMJ Case Rep       Date:  2013-08-02

10.  Bronchial hyperresponsiveness to methacholine in patients with primary Sjögren's syndrome.

Authors:  B Gudbjörnsson; H Hedenström; G Stålenheim; R Hällgren
Journal:  Ann Rheum Dis       Date:  1991-01       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.